WO2024254043A3 - Peptides d'activation nmda-r dans l'inflammation et la différenciation neuronale - Google Patents

Peptides d'activation nmda-r dans l'inflammation et la différenciation neuronale Download PDF

Info

Publication number
WO2024254043A3
WO2024254043A3 PCT/US2024/032364 US2024032364W WO2024254043A3 WO 2024254043 A3 WO2024254043 A3 WO 2024254043A3 US 2024032364 W US2024032364 W US 2024032364W WO 2024254043 A3 WO2024254043 A3 WO 2024254043A3
Authority
WO
WIPO (PCT)
Prior art keywords
nmda
inflammation
neuronal differentiation
peptides
activating peptides
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US2024/032364
Other languages
English (en)
Other versions
WO2024254043A2 (fr
Inventor
Steven L. Gonias
Elisabetta MANTUANO
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California Berkeley
University of California San Diego UCSD
Original Assignee
University of California Berkeley
University of California San Diego UCSD
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California Berkeley, University of California San Diego UCSD filed Critical University of California Berkeley
Publication of WO2024254043A2 publication Critical patent/WO2024254043A2/fr
Publication of WO2024254043A3 publication Critical patent/WO2024254043A3/fr
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/775—Apolipopeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C07K7/06—Linear peptides containing only normal peptide links having 5 to 11 amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Sont proposés dans la description des peptides synthétiques qui répliquent la signalisation cellulaire et les activités biologiques de la PrPc excrétée pleine longueur, et un peptide tétramère synthétique (KPSK), avec deux résidus Lys, dérivés de la structure de P3 et qui présentent une activité anti-inflammatoire large de manière unique.
PCT/US2024/032364 2023-06-07 2024-06-04 Peptides d'activation nmda-r dans l'inflammation et la différenciation neuronale Ceased WO2024254043A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202363506609P 2023-06-07 2023-06-07
US63/506,609 2023-06-07

Publications (2)

Publication Number Publication Date
WO2024254043A2 WO2024254043A2 (fr) 2024-12-12
WO2024254043A3 true WO2024254043A3 (fr) 2025-02-27

Family

ID=93794637

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2024/032364 Ceased WO2024254043A2 (fr) 2023-06-07 2024-06-04 Peptides d'activation nmda-r dans l'inflammation et la différenciation neuronale

Country Status (1)

Country Link
WO (1) WO2024254043A2 (fr)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090130774A1 (en) * 2005-01-13 2009-05-21 David Peretz Elisa assays using prion-specific peptide reagents
US20100291090A1 (en) * 2007-04-26 2010-11-18 Strittmatter Stephen M Prion Protein as a Receptor for Amyloid-Beta Oligomers

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090130774A1 (en) * 2005-01-13 2009-05-21 David Peretz Elisa assays using prion-specific peptide reagents
US20100291090A1 (en) * 2007-04-26 2010-11-18 Strittmatter Stephen M Prion Protein as a Receptor for Amyloid-Beta Oligomers

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
AMARO ET AL.: "Apolipoprotein and LRP1-Based Peptides as New Therapeutic Tools in Atherosclerosis", J CLIN MED, vol. 10, no. 16, 2021, pages 3571 *
BUUS ET AL.: "High-resolution Mapping of Linear Antibody Epitopes Using Ultrahigh- density Peptide Microarrays", MOL CELL PROTEOMICS, vol. 11, no. 12, 2012, pages 1790 - 1800, XP055247517, DOI: 10.1074/mcp.M112.020800 *
MAHABADI ET AL.: "Cellular Prion Protein (PrPc): Putative Interacting Partners and Consequences of the Interaction", INT J MOL SCI., vol. 21, no. 19, 2020, pages 7058 *
MANTUANO ET AL.: "A soluble derivative of PrPC activates cell -signaling and regulates cell physiology through LRP1 and the NMDA receptor", J BIOL CHEM., vol. 295, no. 41, 2020, pages 14178 - 14188, XP093004916, DOI: 10.1074/jbc.RA120.013779 *
MANTUANO ET AL.: "An LRP1-binding motif in cellular prion protein replicates cell - signaling activities of the full-length protein", JCI INSIGHT., vol. 8, no. 15, 8 August 2023 (2023-08-08), pages e170121 *
WIK ET ET AL.: "Separate mechanisms act concurrently to shed and release the prion protein from the cell .", PRION, vol. 6, no. 5, 2012, pages 498 - 509 *

Also Published As

Publication number Publication date
WO2024254043A2 (fr) 2024-12-12

Similar Documents

Publication Publication Date Title
CA2698780C (fr) Utilisation d'analogues du glp-1 dans le traitement des troubles associes a la transmission synaptique dysfonctionnelle
US9062125B2 (en) Use of GIP for the treatment of disorders associated with dysfunctional synaptic transmission
WO2015195509A3 (fr) Procédés et utilisations pour la modulation de l'homéostasie de l'acide biliaire et le traitement de troubles et maladies de l'acide biliaire
HUP0103114A2 (hu) Apolipoprotein A-1 agonisták és alkalmazásuk diszlipidémiás rendellenességek kezelésében
UY25172A1 (es) Curación de fracturas utilizando análogos pthrp
NZ630469A (en) Methods for modulating bile acid homeostasis and treatment of bile acid disorders and diseases
MX361694B (es) Fragmentos de peptidos para inducir sintesis de proteinas de matriz extra-celular.
WO2001096364A3 (fr) Peptides stimulant la survie des cellules et la regenerescence de l'axone
EA201990885A1 (ru) Композиции, содержащие короткие пептиды, полученные из pedf, и их применение
WO2024254043A3 (fr) Peptides d'activation nmda-r dans l'inflammation et la différenciation neuronale
WO2007013944A3 (fr) Utilisation de mutants de cysteine d'il28 et d'il29 tronques pour le traitement de cancers et de troubles autoimmuns
WO2018116165A3 (fr) Complexes thérapeutiquement actifs
WO2017180988A3 (fr) Optimisation peptidique à fgf21 c-terminal
WO2021046398A3 (fr) Polythérapie antivirale contre la rougeole
Gasmi et al. Amino acid structure and characterization of a heterodimeric disintegrin from Vipera lebetina venom
CN108530527A (zh) 一种多肽oa-gl21及其提纯方法与应用
ES2091897T3 (es) Procesamiento in vitro de proteinas de fusion.
WO2019148140A3 (fr) Biomatériaux implantables qui améliorent la survie et la fonction des cellules souches
WO2007071248A3 (fr) Peptides derives de la famille des proteines s-100 favorisant la survie neuritogene et neuronale
DE602005024161D1 (de) Peptid mit antitumoraler wirkung
MX2023012063A (es) Organoides de islotes pancreáticos como fábricas de proteínas.
Wang et al. Plants as a valuable source of bioactive peptides
MX2022008746A (es) Compuestos de peptidos y procedimientos de tratamiento de enfermedades que usan los mismos.
EP4529959A3 (fr) Peptides biomimétiques dérivés d'une source biologique et leurs utilisations pour retarder le vieillissement et améliorer la peau
MX2025007570A (es) Peptido y su uso

Legal Events

Date Code Title Description
NENP Non-entry into the national phase

Ref country code: DE